One year survival of brain tumor patients is closely linked to symptomatic CMV-encephalopathy

Goerig N, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt M, Dörfler A, Engelhorn T, Eyüpoglu IY, Merkel A, Rühle PF, Putz F, Semrau S, Gaipl U, Fietkau R (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Strahlentherapie und Onkologie Urban & Vogel

Book Volume: 193

Pages Range: S151-S152

Authors with CRIS profile

Nicole Goerig Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology Bernhard Fleckenstein Medizinische Fakultät Klaus Überla Lehrstuhl für Klinische und Molekulare Virologie Manuel Schmidt Department of Neuroradiology Arnd Dörfler Department of Neuroradiology Tobias Martin Engelhorn Department of Neuroradiology Ilker Yasin Eyüpoglu Department of Neurosurgery Andreas Merkel Medizinische Fakultät Paul-Friedrich Rühle Department of Radiation Oncology Florian Putz Department of Radiation Oncology Udo Gaipl Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie

How to cite

APA:

Goerig, N., Frey, B., Korn, K., Fleckenstein, B., Überla, K., Schmidt, M.,... Fietkau, R. (2017). One year survival of brain tumor patients is closely linked to symptomatic CMV-encephalopathy. (pp. S151-S152).

MLA:

Goerig, Nicole, et al. "One year survival of brain tumor patients is closely linked to symptomatic CMV-encephalopathy." 2017. S151-S152.

BibTeX: Download